Acurx Pharmaceuticals, Inc.ACXPNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank50
Year-over-Year Change
Year-over-year total asset growth rate
Percentile
P50
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -0.85% |
| Q2 2025 | 28.14% |
| Q1 2025 | 24.56% |
| Q4 2024 | -35.52% |
| Q3 2024 | -9.08% |
| Q2 2024 | -27.76% |
| Q1 2024 | 18.16% |
| Q4 2023 | 7.70% |
| Q3 2023 | -22.50% |
| Q2 2023 | 25.05% |
| Q1 2023 | -21.24% |
| Q4 2022 | -14.33% |
| Q3 2022 | 18.21% |
| Q2 2022 | -18.22% |
| Q1 2022 | -14.58% |
| Q4 2021 | -11.58% |
| Q3 2021 | -14.05% |
| Q2 2021 | 484.88% |
| Q1 2021 | -7.51% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |